Abstract
PCA (2,2,5,5-tetramethylpiperidine-1-oxyl-3-carboxylic acid) is a relatively stable free radical which has been shown to be useful as a contrast agent for nuclear magnetic resonance imaging and as an imaging/spectroscopy agent for EPR. In an effort to determine the role of the liver and kidney in the pharmacokinetics of PCA, using low frequency in vivo EPR spectroscopy, we followed the clearance of PCA after intravenous injection in mice: under normal conditions, with a restricted blood supply to the kidneys, after exposure to an acute hepatotoxin CCl4, and after exposure to lipopolysaccharide (endotoxin). The observed pharmacokinetics fit a two-component model. The fast component was dramatically affected when the renal vessels were restricted, while CCl4 and endotoxin had a smaller but significant effect. The half times of the slow components were not significantly different (p>0.05) in the groups treated by renal blood flow occlusion, CCl4, or LPS, compared with the control group. In conclusion, we find that the pharmacokinetics of PCA need to be completely described in term of a two component model: the fast component of the decay is mainly due to the elimination by the kidneys and also is affected by the time for the initial distribution; the slow component is related to the bioreduction of the nitroxide. In addition to the liver other tissues can also effectively metabolize PCA. The effect of oxygen on the rate of metabolism is modest at most.
Similar content being viewed by others
References
D. Gelvan, P. Saltman, and S.R. Powell, Proc. Natl. Acad. Sci. USA 88, 4680 (1991).
M.C. Krishna, D.A. Grahame, A. Samuni, J.B. Mitchell, and A. Russo, Proc. Natl. Acad. Sci. USA 89, 5537 (1992).
S. M. Hahn, L. Wilson, J. Liebmann, W. De Graff, J. Gamson, A. Samuni, D. Venzon, and J.B. Mitchell, Radiat. Res. 132, 87 (1992).
R.C. Brasch, D.A. London, G.E. Wesbey, T.N. Tozer, D.E. Nitecki, R.D. Williams, J. Doemeny, L. Dallas Tuck, and D.P. Lallemand, Radiology 147, 773 (1983).
B. Gallez, R. Demeure, R. Debuyst, D. Leonard, F. Dejehet, and P. Dumont, Magn. Reson. Imag. 10, 445 (1992).
B. Gallez, R. Debuyst, R. Demeure, F. Dejehet, C. Grandin, B. Van Beers, H. Taper, J. Pringot, and P. Dumont, Magn. Reson. Med. 30, 592 (1993).
B. Gallez, V. Lacour, R. Demeure, R. Debuyst, F. Dejehet, J. L. De Keyser, and P. Dumont, Magn. Reson. Imag. 12, 61 (1994).
H.M. Swartz. In: E. Feig (Ed.), Advances in Magnetic Resonance Imaging, Ablex Publishing Company, Norwood, 1989, p. 49.
H.M. Swartz and T. Walczak, Phys. Med. 9, 41 (1993).
S. Colacicchi, M. Ferrari, and A. Sotgiu, Int. J. Biochem. 24, 205 (1992).
D.J. Lurie, I. Nicholson, M.A. Foster, and J.R. Mallard, Phil. Trans. R. Soc. Lond. A333, 453 (1990).
D. Grucker, D. Guiberteau, B. Eclancher, J. Chambron, R. Chiarelli, A. Rassat, G. Subra and B. Gallez, J. Magn. Reson. B 106, 101 (1995).
R.C. Brasch, Radiology 147, 781 (1983).
G. Bacic, M.J. Nilges, T. Walczak, and H.M. Swartz, Phys. Med. 24, 307 (1989).
M. Ferrari, V. Quaresima, C.L. Ursini, M. Alecci, and A Sotgiu, Int. J. Radiat. Oncology Biol. Phys. 29, 421 (1994).
M Ferrari, S. Colacicchi, G. Gualtieri, M. T. Santini, and A Sotgiu, Biochem. Biophys. Res. Commun. 166, 168 (1990).
V. Quaresima, M. Alecci, M. Ferrari, and A. Sotgiu, Biochem. Biophys. Res. Commun. 183, 829 (1992).
V. Quaresima, C.L. Ursini, G. Gualtieri, A. Sotgiu, and M. Ferrari, Biochim. Biophysica Acta 1182, 115 (1993).
M.G. Eriksson, M.D. Ogan, C.T. Peng, C.R. Brasch, and T.N. Tozer, Magn. Reson. Med. 5, 73 (1987).
M. Sentjurc, D.V. Apte, L. MacAllister, and H.M. Swartz, Curr. Topics in Biophys. 18, 81 (1994).
H.M. Swartz, M. Sentjurc, and P.D. Morse II Biochim. Biophy. Acta 888, 82 (1986).
M.J. Nilges, T. Walczak, and H.M. Swartz, Phys. Med. 2, 195 (1989).
A.M. Komarov, J. Joseph, and C.S. Lai, Biochem. Biophys. Res. Commun. 201, 1035 (1994).
B. Gallez, G. Bacic, F. Goda, J. Jiang, J.A. O’Hara, J.F. Dunn, and H.M. Swartz, Magn. Reson. Med. in press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goda, F., Gallez, B. & Swartz, H.M. Pharmacokinetics of the nitroxide PCA measured by in vivo EPR. Res. Chem. Intermed. 22, 491–498 (1996). https://doi.org/10.1163/156856796X00692
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1163/156856796X00692